ABVX CIK: 1956827

Abivax S.A.

  • France
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−45.0
FY22:
−53.9
FY23:
−97.1
FY24:
−154
FY25:
−161
Change from FY21 to FY25
millions EUR
FY21:
−6.23
FY22:
−12.0
FY23:
−8.10
FY24:
15.8
FY25:
−8.19
Change from FY21 to FY25
millions EUR
FY21:
82.7
FY22:
32.2
FY23:
335
FY24:
28.2
FY25:
547
millions EUR
FY21:
31.4
FY22:
−33.8
FY23:
225
FY24:
−108
FY25:
372
(positive)
Change from FY21 to FY25
millions EUR
FY21:
−45.1
FY22:
−54.2
FY23:
−97.4
FY24:
−155
FY25:
−161

All amounts in millions EUR Data source:SEC EDGAR